Slovea Chankova

Slovea Cankova, Healthcare correspondent for The Economist, and Tom Nuttall, Berlin bureau chief for The Economist, dive into the paradox of rising cancer rates amid medical advancements. They discuss breakthroughs in treatment, the importance of early detection, and the challenges in cancer research funding. On a different note, they explore how economic pressures affect the food industry, spotlighting Kraft Heinz's struggles and the intertwining of sports and politics in Germany, particularly with far-right influences in football.

In this engaging discussion, Slovea Cankova, a Healthcare correspondent for The Economist, delves into recent advancements in cancer treatment, spotlighting innovative therapies and breakthroughs that shape patient care. Despite the rising cancer mortality rates, she emphasizes how modern medicine is making strides in lessening the disease's deadliness. The conversation also touches on the challenges the food industry faces, particularly with changing consumer habits that affect major brands like Kraft Heinz, weaving in the complexities of politics and consumer preferences.

Slovea Cankova, The Economist's healthcare correspondent, offers sharp insights into the Omicron variant's global impact and the critical need for ongoing research. Mike Bird, the Asia business and finance editor, reveals Vietnam's burgeoning class of billionaires and how government support is fostering competitive firms. Fascinatingly, they draw parallels between bees' natural social distancing and human responses to pathogens, showcasing lessons from the natural world amid ongoing health crises.